EntryID	Reaction	Organism	ECNumber	parameter.type	parameter.associatedSpecies	parameter.startValue	parameter.endValue	parameter.standardDeviation	parameter.unit	UniProtKB_AC	Enzyme Variant	Enzymename	Publication	PubMedID	Substrate	Product	Temperature	pH	Rate Equation
66772	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	3.4.17.23	Kd	ACE2	1.4700000000000001E-8		-	M	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	-	8.0	-
66772	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	3.4.17.23	concentration	ACE2	1.56E-8	2.5000000000000004E-7	-	M	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	-	8.0	-
66772	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	3.4.17.23	Association constant	ACE2	188000.0		-	M^(-1)*s^(-1)	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	-	8.0	-
66772	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	3.4.17.23	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	-	8.0	-
66772	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	3.4.17.23	rate const.		0.00276		-	s^(-1)	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	-	8.0	-
66773	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS coronavirus	3.4.17.23	rate const.		0.112		-	s^(-1)	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	Spike glycoprotein RBD-SD1;ACE2	Spike glycoprotein RBD-SD1-ACE2 complex	-	8.0	-
66773	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS coronavirus	3.4.17.23	Association constant	ACE2	362000.0		-	M^(-1)*s^(-1)	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	Spike glycoprotein RBD-SD1;ACE2	Spike glycoprotein RBD-SD1-ACE2 complex	-	8.0	-
66773	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS coronavirus	3.4.17.23	Kd	ACE2	3.258E-7		-	M	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	Spike glycoprotein RBD-SD1;ACE2	Spike glycoprotein RBD-SD1-ACE2 complex	-	8.0	-
66773	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS coronavirus	3.4.17.23	concentration	ACE2	3.13E-8	5.000000000000001E-7	-	M	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	Spike glycoprotein RBD-SD1;ACE2	Spike glycoprotein RBD-SD1-ACE2 complex	-	8.0	-
66773	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS coronavirus	3.4.17.23	concentration	Spike glycoprotein RBD-SD1			-	-	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	Spike glycoprotein RBD-SD1;ACE2	Spike glycoprotein RBD-SD1-ACE2 complex	-	8.0	-
66774	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS-CoV-2	3.4.17.23	rate const.		0.0047		-	s^(-1)	Q9BYF1;P0DTC2	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein RBD-SD1	Spike glycoprotein RBD-SD1-ACE2 complex	-	7.5	-
66774	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS-CoV-2	3.4.17.23	concentration	ACE2	1.0000000000000001E-7		-	M	Q9BYF1;P0DTC2	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein RBD-SD1	Spike glycoprotein RBD-SD1-ACE2 complex	-	7.5	-
66774	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS-CoV-2	3.4.17.23	Kd	Spike glycoprotein RBD-SD1	3.4600000000000005E-8		-	M	Q9BYF1;P0DTC2	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein RBD-SD1	Spike glycoprotein RBD-SD1-ACE2 complex	-	7.5	-
66774	ACE2 + Spike glycoprotein RBD-SD1 = Spike glycoprotein RBD-SD1-ACE2 complex	SARS-CoV-2	3.4.17.23	Association constant	Spike glycoprotein RBD-SD1	136000.0		-	M^(-1)*s^(-1)	Q9BYF1;P0DTC2	wildtype	angiotensin-converting enzyme 2	Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh CL, Abiona O, Graham BS, McLellan JS: Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science 2020 (367) , 1260-1263	32075877	ACE2;Spike glycoprotein RBD-SD1	Spike glycoprotein RBD-SD1-ACE2 complex	-	7.5	-
67065	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein RBD	0.001		-	mg/ml	P0DTC2;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67065	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS-CoV-2	-	concentration	hACE2	1.0	1.0	-	mg/ml	P0DTC2;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67065	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS-CoV-2	-	EC50	Spike glycoprotein RBD	0.00107		1.0E-4	mg/ml	P0DTC2;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67066	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS coronavirus	-	concentration	Spike glycoprotein RBD	0.001		-	mg/ml	P59594;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67066	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS coronavirus	-	EC50	hACE2	166.0		4.6E-4	mg/ml	P59594;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67066	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS coronavirus	-	concentration	hACE2	1.0	1.0	-	mg/ml	P59594;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	37.0	-	-
67067	Spike glycoprotein RBD + DPP4 = Spike glycoprotein RBD-DPP4 complex	Middle East respiratory syndrome-related coronavirus	-	EC50	DPP4	9.2E-4		4.6E-4	mg/ml	P27487;K0BRG7	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	DPP4;Spike glycoprotein RBD	Spike glycoprotein RBD-DPP4 complex	37.0	-	-
67067	Spike glycoprotein RBD + DPP4 = Spike glycoprotein RBD-DPP4 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	DPP4	1.0E-5	0.01	-	mg/ml	P27487;K0BRG7	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	DPP4;Spike glycoprotein RBD	Spike glycoprotein RBD-DPP4 complex	37.0	-	-
67067	Spike glycoprotein RBD + DPP4 = Spike glycoprotein RBD-DPP4 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	Spike glycoprotein RBD	0.001		-	mg/ml	P27487;K0BRG7	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	DPP4;Spike glycoprotein RBD	Spike glycoprotein RBD-DPP4 complex	37.0	-	-
67068	Spike glycoprotein RBD + bACE2 = Spike glycoprotein RBD-bACE2 complex	SARS-CoV-2	-	EC50	Spike glycoprotein RBD	8.0E-5		2.0E-5	mg/ml	P0DTC2;G1PXH7	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	Spike glycoprotein RBD;bACE2	Spike glycoprotein RBD-bACE2 complex	22.0	-	-
67069	Spike glycoprotein RBD + bACE2 = Spike glycoprotein RBD-bACE2 complex	SARS coronavirus	-	EC50	Spike glycoprotein RBD	9.6E-4		1.0E-5	mg/ml	P59594;G1PXH7	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	bACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-bACE2 complex	22.0	-	-
67070	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS-CoV-2	-	EC50	Spike glycoprotein RBD	1.4000000000000001E-4		5.0E-5	mg/ml	P0DTC2;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	22.0	-	-
67071	hACE2 + Spike glycoprotein RBD = Spike glycoprotein RBD-hACE2 complex	SARS coronavirus	-	EC50	Spike glycoprotein RBD	0.00132		8.999999999999999E-5	mg/ml	P59594;Q9BYF1	wildtype		Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;Spike glycoprotein RBD	Spike glycoprotein RBD-hACE2 complex	22.0	-	-
67072	hACE2 + SARS-CoV-2 pseudovirus = hACE2 + SARS-CoV-2 pseudovirus	Homo sapiens	3.4.17.23	IC50	Spike glycoprotein RBD	0.00135		5.4E-4	mg/ml	P0DTC2;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	SARS-CoV-2 pseudovirus;hACE2	hACE2;SARS-CoV-2 pseudovirus	37.0	-	-
67073	hACE2 + SARS-CoV pseudovirus = hACE2 + SARS-CoV pseudovirus	Homo sapiens	3.4.17.23	IC50	Spike glycoprotein RBD	0.00547		3.0E-4	mg/ml	P59594;Q9BYF1;P0DTC2	wildtype	angiotensin-converting enzyme 2	Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;SARS-CoV pseudovirus	hACE2;SARS-CoV pseudovirus	37.0	-	-
67074	hACE2 + SARS-CoV-2 pseudovirus = hACE2 + SARS-CoV-2 pseudovirus	Homo sapiens	3.4.17.23	IC50	Spike glycoprotein RBD	0.011630000000000001		0.00173	mg/ml	P0DTC2;Q9BYF1;P59594	wildtype	angiotensin-converting enzyme 2	Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	SARS-CoV-2 pseudovirus;hACE2	SARS-CoV-2 pseudovirus;hACE2	37.0	-	-
67075	hACE2 + SARS-CoV pseudovirus = hACE2 + SARS-CoV pseudovirus	Homo sapiens	3.4.17.23	IC50	Spike glycoprotein RBD	0.0040999999999999995		7.0E-4	mg/ml	P59594;Q9BYF1	wildtype	angiotensin-converting enzyme 2	Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hACE2;SARS-CoV pseudovirus	SARS-CoV pseudovirus;hACE2	37.0	-	-
67076	hDPP4 + MERS-CoV pseudovirus = hDPP4 + MERS-CoV pseudovirus	Homo sapiens	3.4.17.23	IC50	Spike glycoprotein RBD	0.02225		4.3E-4	mg/ml	K0BRG7;P27487	wildtype	angiotensin-converting enzyme 2	Tai W, He L, Zhang X, Pu J, Voronin D, Jiang S, Zhou Y, Du L: Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine, Cell Mol Immunol 2020 (17) , 613-620	32203189	hDPP4;MERS-CoV pseudovirus	MERS-CoV pseudovirus;hDPP4	37.0	-	-
67429	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	2.0E-6		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	-	7.3	Vmax*S/(Km+S)
67429	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	4.9999999999999996E-6	6.399999999999999E-4	-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	-	7.3	Vmax*S/(Km+S)
67429	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	kcat/Km	Dabcyl-KTSAVLQSGFRKM-Edans	3426.1		416.9	M^(-1)*s^(-1)	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	-	7.3	Vmax*S/(Km+S)
67429	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	Vmax				-	-	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	-	7.3	Vmax*S/(Km+S)
67429	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	Km	Dabcyl-KTSAVLQSGFRKM-Edans			-	-	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	-	7.3	Vmax*S/(Km+S)
67430	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	4.9999999999999996E-6	6.399999999999999E-4	-	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	-	7.3	Vmax*S/(Km+S)
67430	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	concentration	Enzyme	2.0E-6		-	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	-	7.3	Vmax*S/(Km+S)
67430	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	kcat/Km	Dabcyl-KTSAVLQSGFRKM-Edans	3011.3		294.6	M^(-1)*s^(-1)	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	-	7.3	Vmax*S/(Km+S)
67430	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	Km	Dabcyl-KTSAVLQSGFRKM-Edans			-	-	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	-	7.3	Vmax*S/(Km+S)
67430	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	Vmax				-	-	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	-	7.3	Vmax*S/(Km+S)
67431	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	IC50	(3S)-N-Benzyl-3-[[(2S)-3-cyclohexyl-2-[[(E)-3-phenylprop-2-enoyl]amino]propanoyl]amino]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butanamide	1.8E-7		2.0E-8	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
67431	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
67431	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	1.9999999999999998E-5		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
67431	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	(3S)-N-Benzyl-3-[[(2S)-3-cyclohexyl-2-[[(E)-3-phenylprop-2-enoyl]amino]propanoyl]amino]-2-oxo-4-[(3S)-2-oxopyrrolidin-3-yl]butanamide	0.0	9.999999999999999E-5	-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	SGFRKM-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
67432	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	tert-Butyl (1-((S)-3-cyclohexyl-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3- yl)butan-2-yl)amino)-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	0.0	9.999999999999999E-5	-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67432	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67432	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	1.9999999999999998E-5		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67432	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	IC50	tert-Butyl (1-((S)-3-cyclohexyl-1-(((S)-4-(cyclopropylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3- yl)butan-2-yl)amino)-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	2.39E-6		6.3E-7	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67433	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	1.9999999999999998E-5		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67433	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	IC50	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	6.7E-7		1.8E-7	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67433	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67433	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS-CoV-2	3.4.22.69	concentration	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	0.0	9.999999999999999E-5	-	M	P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67434	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67434	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	concentration	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	0.0	9.999999999999999E-5	-	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67434	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	IC50	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	9.0E-7		2.9E-7	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67434	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	1.9999999999999998E-5		-	M	P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	Dabcyl-KTSAVLQSGFRKM-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67435	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKM-Edans	1.9999999999999998E-5		-	M	P0C6T4	wildtype Mpro (aa 3292-3597)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67435	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6T4	wildtype Mpro (aa 3292-3597)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67435	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	IC50	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	5.8E-7		2.1999999999999998E-7	M	P0C6T4	wildtype Mpro (aa 3292-3597)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
67435	H2O + Dabcyl-KTSAVLQSGFRKM-Edans = SGFRKM-Edans + Dabcyl-KTSAVLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	tert-Butyl (1-((S)-1-(((S)-4-(benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)-butan-2-yl)amino)- 3-cyclopropyl-1-oxopropan-2-yl)-2-oxo-1,2-dihydropyridin-3-yl)carbamate	0.0	9.999999999999999E-5	-	M	P0C6T4	wildtype Mpro (aa 3292-3597)	SARS coronavirus main proteinase	Zhang L, Lin D, Sun X, Curth U, Drosten C, Sauerhering L, Becker S, Rox K, Hilgenfeld R: Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors, Science 2020 (368) , 409-412	32198291	H2O;Dabcyl-KTSAVLQSGFRKM-Edans	Dabcyl-KTSAVLQ;SGFRKM-Edans	37.0	7.3	-
68363	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68363	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68363	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68363	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.22E-6		1.2E-7	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68364	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	6.559999999999999E-6		3.1E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68364	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68364	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68364	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68365	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68365	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.95E-6		2.4E-7	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68365	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68365	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68366	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-(4-fluorophenyl)-propanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68366	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68366	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68366	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-(4-fluorophenyl)-propanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	2.32E-6		1.2099999999999998E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68367	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68367	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-(4-fluorophenyl)-propanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	8.69E-6		1.28E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68367	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68367	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-(4-fluorophenyl)-propanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68368	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	1.38E-5		4.17E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68368	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68368	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68368	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68369	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68369	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	3.82E-6		1.2099999999999998E-6	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68369	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68369	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68370	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68370	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68370	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	3.3E-7		4.0E-8	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68370	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68371	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68371	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68371	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	1.08E-6		9.0E-8	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68371	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68372	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68372	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68372	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68372	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	3.24E-6		1.69E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68373	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68373	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	5.2E-6		2.8E-7	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68373	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68373	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68374	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	8.5E-6		3.7099999999999996E-6	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68374	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68374	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidohexanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68374	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68375	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68375	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	8.5E-6		1.81E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68375	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68375	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68376	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68376	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	8.93E-6		2.39E-6	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68376	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68376	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68377	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	1.068E-5		7.339999999999999E-6	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68377	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68377	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68377	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68378	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68378	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	0.0	9.999999999999999E-5	-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68378	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamidopent-4-ynamide	1.737E-5		3.97E-6	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68378	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68379	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68379	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68379	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68379	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.538E-5		4.1199999999999995E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68380	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68380	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68380	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68380	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	6.269999999999999E-6		2.87E-6	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68381	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.15E-5		5.05E-6	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68381	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68381	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68381	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-2-cyclopropylacetamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68382	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68382	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68382	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68382	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.69E-6		4.6999999999999995E-7	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68383	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68383	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68383	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	9.499999999999999E-7		1.5E-7	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68383	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68384	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	7.1E-7		3.6E-7	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68384	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68384	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68384	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68385	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68385	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68385	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclohexylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.227E-5		3.56E-6	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68385	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68386	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68386	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.8469999999999998E-5		4.25E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68386	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68386	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68387	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68387	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	4.25E-6		1.4E-6	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68387	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68387	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68388	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68388	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68388	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	2.4E-7		8.0E-8	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68388	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68389	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68389	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68389	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68389	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopropylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.37E-6		3.5E-7	M	P0C6U6;P0C6X5	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68390	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68390	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68390	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68390	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.081E-5		2.62E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68391	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	4.78E-6		1.1299999999999998E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68391	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68391	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68391	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68392	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68392	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68392	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.44E-6		4.0E-7	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68392	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68393	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	3.43E-6		2.4500000000000003E-6	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68393	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68393	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclobutylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68393	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68394	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	4.7300000000000005E-6		9.399999999999999E-7	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68394	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68394	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68394	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68395	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.9299999999999997E-6		4.2999999999999996E-7	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68395	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68395	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68395	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68396	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68396	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68396	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.27E-6		3.4000000000000003E-7	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68396	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68397	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68397	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	Enzyme	5.0E-7		-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68397	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	concentration	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68397	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	Human coronavirus NL63	3.4.22	IC50	(S)-N-Benzyl-3-((S)-2-cinnamamido-3-cyclopentylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	5.41E-6		2.31E-6	M	P0C6X5;P0C6U6	wildtype Mpro (aa 2940-3240)	Cysteine endopeptidases	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68398	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Butyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	2.3799999999999997E-6		5.8E-7	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68398	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Butyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68398	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68398	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68399	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68399	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68399	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Butyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.0E-6		3.5E-7	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68399	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Butyl-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68400	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	1.9039999999999997E-5		5.79E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68400	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68400	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68400	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68401	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	9.859999999999999E-6		2.68E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68401	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68401	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68401	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68402	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68402	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	4.319E-5		2.4679999999999997E-5	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68402	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-(tert-Butyl)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68402	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68403	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68403	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68403	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	1.766E-5		8.779999999999999E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68403	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68404	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68404	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68404	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68404	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	6.5E-6		5.8E-7	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68405	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68405	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68405	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-((S)-4-(Isobutylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)-2-cinnamamido-4-methylpentanamide	1.1369999999999998E-5		4.64E-6	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68405	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KTSAVLQSGFRKME-Edans;H2O	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68406	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68406	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68406	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68406	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	1.114E-5		2.64E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68407	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	9.91E-6		1.84E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68407	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68407	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68407	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68408	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68408	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	Methyl 2-((S)-3-((S)-2-cinnamamido-3-phenylpropanamido)-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)butanamido)acetate	4.4699999999999996E-6		2.4900000000000003E-6	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68408	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68408	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68409	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68409	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68409	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68409	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	4.57E-6		1.04E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68410	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68410	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68410	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	3.5E-6		1.06E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68410	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68411	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	3.5899999999999995E-6		2.4E-7	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68411	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	(S)-N-Benzyl-2-oxo-4-((S)-2-oxopyrrolidin-3-yl)-3-((S)-3-phenyl-2-(3-phenylpropanamido)propanamido)butanamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68411	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68411	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68412	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	4.749999999999999E-6		2.7299999999999997E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68412	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68412	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68412	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68413	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68413	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	3.66E-6		7.9E-7	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68413	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68413	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68414	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68414	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	1.073E-5		3.5499999999999995E-6	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68414	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68414	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68415	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	9.74E-6		3.88E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68415	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68415	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68415	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68416	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68416	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	4.8200000000000004E-6		1.1699999999999998E-6	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68416	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68416	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68417	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	1.188E-5		5.29E-6	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68417	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68417	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-5-carboxamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68417	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68418	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68418	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	1.13E-5		6.519999999999999E-6	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68418	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	0.0	9.999999999999999E-5	-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68418	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Enterovirus A71	3.4.22.28	concentration	Enzyme	3.0E-6		-	M	F6KTB0	wildtype 3Cpro (aa 1548-1731)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68419	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	9.189999999999998E-6		2.99E-6	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68419	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68419	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	0.0	9.999999999999999E-5	-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68419	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	Q5UEA2;P03313	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KEALFQGPPQFE-Edans	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68420	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	1.671E-5		6.9599999999999994E-6	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68420	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68420	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68420	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzofuran-2-carboxamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	SGFRKME-Edans;Dabcyl-KTSAVLQ	37.0	7.3	-
68421	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68421	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzo[b]thiophene-2-carboxamide	1.856E-5		5.8E-7	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68421	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzo[b]thiophene-2-carboxamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68421	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	GPPQFE-Edans;Dabcyl-KEALFQ	37.0	7.3	-
68422	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68422	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68422	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzo[b]thiophene-2-carboxamide	0.0	9.999999999999999E-5	-	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68422	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)benzo[b]thiophene-2-carboxamide	9.679999999999999E-6		2.91E-6	M	P0C6X7;P0C6U8	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68423	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-6-bromoimidazo[1,2-a]pyridine-2-carboxamide	3.078E-5		1.292E-5	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68423	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Enzyme	2.0E-6		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68423	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	Dabcyl-KEALFQGPPQFE-Edans	1.9999999999999998E-5		-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68423	H2O + Dabcyl-KEALFQGPPQFE-Edans = GPPQFE-Edans + Dabcyl-KEALFQ	Coxsackievirus B3	3.4.22.28	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-6-bromoimidazo[1,2-a]pyridine-2-carboxamide	0.0	9.999999999999999E-5	-	M	P03313;Q5UEA2	wildtype 3Cpro (aa 1540-1723)	picornain 3C	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	Dabcyl-KEALFQGPPQFE-Edans;H2O	Dabcyl-KEALFQ;GPPQFE-Edans	37.0	7.3	-
68424	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Enzyme	5.0E-7		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68424	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-6-bromoimidazo[1,2-a]pyridine-2-carboxamide	0.0	9.999999999999999E-5	-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68424	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	IC50	N-((S)-1-(((S)-4-(Benzylamino)-3,4-dioxo-1-((S)-2-oxopyrrolidin-3-yl)butan-2-yl)amino)-1-oxo-3-phenylpropan-2-yl)-6-bromoimidazo[1,2-a]pyridine-2-carboxamide	1.325E-5		1.09E-6	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
68424	H2O + Dabcyl-KTSAVLQSGFRKME-Edans = Dabcyl-KTSAVLQ + SGFRKME-Edans	SARS coronavirus	3.4.22.69	concentration	Dabcyl-KTSAVLQSGFRKME-Edans	1.9999999999999998E-5		-	M	P0C6U8;P0C6X7	wildtype Mpro (aa 3241-3546)	SARS coronavirus main proteinase	Zhang L, Lin D, Kusov Y, Nian Y, Ma Q, Wang J, von Brunn A, Leyssen P, Lanko K, Neyts J, de Wilde A, Snijder EJ, Liu H, Hilgenfeld R: α-Ketoamides as Broad- Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment, J Med Chem 2020 (63) , 4562-4578	32045235	H2O;Dabcyl-KTSAVLQSGFRKME-Edans	Dabcyl-KTSAVLQ;SGFRKME-Edans	37.0	7.3	-
69803	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	3.118E-4		3.65E-5	M	H8WGE8;H8WGE2	mutant Lac3A/S, chimeric LacA (domain1 and 2)/LacS (domain 3) from Bacillus subtilis LS02	laccase	Wang J, Yu S, Li X, Feng F, Lu L: High-level expression of Bacillus amyloliquefaciens laccase and construction of its chimeric variant with improved stability by domain substitution, Bioprocess Biosyst Eng 2020 (43) , 403-411	31673777	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.0	-
69803	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	kcat		42.0		2.8	s^(-1)	H8WGE8;H8WGE2	mutant Lac3A/S, chimeric LacA (domain1 and 2)/LacS (domain 3) from Bacillus subtilis LS02	laccase	Wang J, Yu S, Li X, Feng F, Lu L: High-level expression of Bacillus amyloliquefaciens laccase and construction of its chimeric variant with improved stability by domain substitution, Bioprocess Biosyst Eng 2020 (43) , 403-411	31673777	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.0	-
69803	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	4.9999999999999996E-5	0.001	-	M	H8WGE8;H8WGE2	mutant Lac3A/S, chimeric LacA (domain1 and 2)/LacS (domain 3) from Bacillus subtilis LS02	laccase	Wang J, Yu S, Li X, Feng F, Lu L: High-level expression of Bacillus amyloliquefaciens laccase and construction of its chimeric variant with improved stability by domain substitution, Bioprocess Biosyst Eng 2020 (43) , 403-411	31673777	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.0	-
69803	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	130000.0		-	M^(-1)*s^(-1)	H8WGE8;H8WGE2	mutant Lac3A/S, chimeric LacA (domain1 and 2)/LacS (domain 3) from Bacillus subtilis LS02	laccase	Wang J, Yu S, Li X, Feng F, Lu L: High-level expression of Bacillus amyloliquefaciens laccase and construction of its chimeric variant with improved stability by domain substitution, Bioprocess Biosyst Eng 2020 (43) , 403-411	31673777	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.0	-
69804	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2530.0		-	M^(-1)*s^(-1)	A0A6C0GY11	wildtype His-tagged	laccase	Wang H, Huang L, Li Y, Ma J, Wang S, Zhang Y, Ge X, Wang N, Lu F, Liu Y: Characterization and application of a novel laccase derived from Bacillus amyloliquefaciens, Int J Biol Macromol 2020 (150) , 982-990	31759024	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	80.0	5.5	Vmax*S/(Km+S)
69804	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	0.0019		-	M	A0A6C0GY11	wildtype His-tagged	laccase	Wang H, Huang L, Li Y, Ma J, Wang S, Zhang Y, Ge X, Wang N, Lu F, Liu Y: Characterization and application of a novel laccase derived from Bacillus amyloliquefaciens, Int J Biol Macromol 2020 (150) , 982-990	31759024	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	80.0	5.5	Vmax*S/(Km+S)
69804	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	kcat		4.8		-	s^(-1)	A0A6C0GY11	wildtype His-tagged	laccase	Wang H, Huang L, Li Y, Ma J, Wang S, Zhang Y, Ge X, Wang N, Lu F, Liu Y: Characterization and application of a novel laccase derived from Bacillus amyloliquefaciens, Int J Biol Macromol 2020 (150) , 982-990	31759024	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	80.0	5.5	Vmax*S/(Km+S)
69804	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	Vmax		8.316666666666668E-5		-	mol*s^(-1)*g^(-1)	A0A6C0GY11	wildtype His-tagged	laccase	Wang H, Huang L, Li Y, Ma J, Wang S, Zhang Y, Ge X, Wang N, Lu F, Liu Y: Characterization and application of a novel laccase derived from Bacillus amyloliquefaciens, Int J Biol Macromol 2020 (150) , 982-990	31759024	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	80.0	5.5	Vmax*S/(Km+S)
69804	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus amyloliquefaciens	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	0.006		-	M	A0A6C0GY11	wildtype His-tagged	laccase	Wang H, Huang L, Li Y, Ma J, Wang S, Zhang Y, Ge X, Wang N, Lu F, Liu Y: Characterization and application of a novel laccase derived from Bacillus amyloliquefaciens, Int J Biol Macromol 2020 (150) , 982-990	31759024	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	80.0	5.5	Vmax*S/(Km+S)
69811	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus sp.	1.10.3.2	kcat		22.8		-	s^(-1)	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	Syringaldazine;O2	H2O;Oxidized syringaldazine	50.0	6.8	(E*kcat)*S/(Km+S)
69811	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus sp.	1.10.3.2	concentration	Enzyme	2.1E-4		-	mg/ml	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	Syringaldazine;O2	H2O;Oxidized syringaldazine	50.0	6.8	(E*kcat)*S/(Km+S)
69811	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus sp.	1.10.3.2	Km	Syringaldazine	1.58E-5		-	M	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	Syringaldazine;O2	H2O;Oxidized syringaldazine	50.0	6.8	(E*kcat)*S/(Km+S)
69811	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus sp.	1.10.3.2	concentration	Syringaldazine	4.9999999999999996E-6	7.0E-5	-	M	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	Syringaldazine;O2	H2O;Oxidized syringaldazine	50.0	6.8	(E*kcat)*S/(Km+S)
69812	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus sp.	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.8779E-4		-	M	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	6.8	(E*kcat)*S/(Km+S)
69812	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus sp.	1.10.3.2	kcat		77.9		-	s^(-1)	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	6.8	(E*kcat)*S/(Km+S)
69812	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus sp.	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	9.999999999999999E-5	-	M	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	6.8	(E*kcat)*S/(Km+S)
69812	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus sp.	1.10.3.2	concentration	Enzyme	2.1E-4		-	mg/ml	A0A1L2YVJ3	wildtype LACREC3	laccase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	6.8	(E*kcat)*S/(Km+S)
69813	H2O + O2 + Mn2+ = H+ + Manganese dioxide	Bacillus sp.	1.16.3.3	concentration	Mn2+	0.0025	0.025	-	M	A0A1L2YVJ3	wildtype LACREC3	manganese oxidase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;Mn2+;H2O	Manganese dioxide;H+	37.0	8.0	Vmax*S/(Km+S)
69813	H2O + O2 + Mn2+ = H+ + Manganese dioxide	Bacillus sp.	1.16.3.3	Km	Mn2+	0.03528		-	M	A0A1L2YVJ3	wildtype LACREC3	manganese oxidase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;Mn2+;H2O	Manganese dioxide;H+	37.0	8.0	Vmax*S/(Km+S)
69813	H2O + O2 + Mn2+ = H+ + Manganese dioxide	Bacillus sp.	1.16.3.3	Vmax		1.0333333333333333E-5		-	M*s^(-1)	A0A1L2YVJ3	wildtype LACREC3	manganese oxidase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;Mn2+;H2O	Manganese dioxide;H+	37.0	8.0	Vmax*S/(Km+S)
69813	H2O + O2 + Mn2+ = H+ + Manganese dioxide	Bacillus sp.	1.16.3.3	concentration	Cu2+	6.0E-4		-	M	A0A1L2YVJ3	wildtype LACREC3	manganese oxidase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;Mn2+;H2O	Manganese dioxide;H+	37.0	8.0	Vmax*S/(Km+S)
69813	H2O + O2 + Mn2+ = H+ + Manganese dioxide	Bacillus sp.	1.16.3.3	kcat		19.14		-	s^(-1)	A0A1L2YVJ3	wildtype LACREC3	manganese oxidase	Das R, Liang Z, Li G, An T: A non-blue laccase of Bacillus sp. GZB displays manganese-oxidase activity: A study of laccase characterization, Mn(II) oxidation and prediction of Mn(II) oxidation mechanism, Chemosphere 2020 (252) , 126619	32443277	O2;Mn2+;H2O	Manganese dioxide;H+	37.0	8.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Cu2+	0.005		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	954329.89		-	M^(-1)*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	0.0014399999999999999		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat		1378.09		-	s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Vmax		0.00229		-	M*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69818	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Enzyme	1.6599999999999998E-6		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	37.0	3.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Km	2,6-Dimethoxyphenol	0.00984		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Enzyme	1.6599999999999998E-6		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Cu2+	0.005		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat		6939.89		-	s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Vmax		0.01153		-	M*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	2,6-Dimethoxyphenol			-	-		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69819	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat/Km	2,6-Dimethoxyphenol	705122.82		-	M^(-1)*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	37.0	8.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Cu2+	0.005		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Enzyme	1.6599999999999998E-6		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Km	Syringaldazine	2.4E-4		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	Vmax		2.4E-4		-	M*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Syringaldazine			-	-		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat		145.2		-	s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69820	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat/Km	Syringaldazine	596372.12		-	M^(-1)*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Syringaldazine	H2O;Oxidized syringaldazine	25.0	4.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat/Km	Guaiacol	516411.45		-	M^(-1)*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Guaiacol			-	-		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	kcat		2184.2		-	s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Enzyme	9.0E-7		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	Km	Guaiacol	0.00422		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	Vmax		0.00196		-	M*s^(-1)		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69821	O2 + Guaiacol = H2O + Oxidized guaiacol	Alkalihalobacillus ligniniphilus	1.10.3.2	concentration	Cu2+	0.005		-	M		wildtype	laccase	Zhu D, Liang N, Zhang R, Ahmad F, Zhang W, Yang B, Wu J, Geng A, Gabriel M, Sun J: Insight into Depolymerization Mechanism of Bacterial Laccase for Lignin, ACS Sustainable Chem Eng 2020 (8 (34)) , 12920-12933		O2;Guaiacol	Oxidized guaiacol;H2O	50.0	3.0	Vmax*S/(Km+S)
69822	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	Vmax		2.3266666666666667E-8		-	mol/s		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	5.0	Vmax*S/(Km+S)
69822	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	kcat		102.1		-	s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	5.0	Vmax*S/(Km+S)
69822	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	5.0	Vmax*S/(Km+S)
69822	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.8449999999999999E-4		-	M		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	5.0	Vmax*S/(Km+S)
69822	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	553000.0		-	M^(-1)*s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	5.0	Vmax*S/(Km+S)
69823	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	Km	2,6-Dimethoxyphenol	4.407E-4		-	M		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	50.0	8.0	Vmax*S/(Km+S)
69823	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	Vmax		7.74E-9		-	mol/s		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	50.0	8.0	Vmax*S/(Km+S)
69823	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,6-Dimethoxyphenol			-	-		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	50.0	8.0	Vmax*S/(Km+S)
69823	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	kcat/Km	2,6-Dimethoxyphenol	227500.0		-	M^(-1)*s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	50.0	8.0	Vmax*S/(Km+S)
69823	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	kcat		100.3		-	s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	50.0	8.0	Vmax*S/(Km+S)
69824	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	5.0	Vmax*S/(Km+S)
69824	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	kcat		103.0		-	s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	5.0	Vmax*S/(Km+S)
69824	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.615E-4		-	M		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	5.0	Vmax*S/(Km+S)
69824	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	Vmax		2.0900000000000002E-8		-	mol/s		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	5.0	Vmax*S/(Km+S)
69824	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	394000.0		-	M^(-1)*s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	5.0	Vmax*S/(Km+S)
69825	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	kcat		103.1		-	s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	50.0	8.0	Vmax*S/(Km+S)
69825	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,6-Dimethoxyphenol			-	-		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	50.0	8.0	Vmax*S/(Km+S)
69825	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	Km	2,6-Dimethoxyphenol	5.367999999999999E-4		-	M		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	50.0	8.0	Vmax*S/(Km+S)
69825	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	Vmax		5.366666666666667E-9		-	mol/s		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	50.0	8.0	Vmax*S/(Km+S)
69825	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	kcat/Km	2,6-Dimethoxyphenol	192000.0		-	M^(-1)*s^(-1)		wildtype	laccase	Sharma V, Upadhyay LS, Vasanth D: Extracellular Thermostable Laccase-Like Enzymes from Bacillus licheniformis Strains: Production, Purification and Characterization, Appl Biochem Microbiol 2020 (56) , 420-432		O2;2,6-Dimethoxyphenol	Oxidized donor;H2O	50.0	8.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	76.0		-	M^(-1)*s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	kcat		0.3		0.03	s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	Vmax				-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	0.0039900000000000005		0.00107	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	concentration	Cu2+	1.0E-4		-	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69990	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Geobacillus sp. JS12	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	70.0	3.0	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	kcat		45.17		2.82	s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	Vmax				-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	kcat/Km	2,6-Dimethoxyphenol	10680.0		-	M^(-1)*s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	Km	2,6-Dimethoxyphenol	0.00423		5.9E-4	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	concentration	Cu2+	1.0E-4		-	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69991	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Geobacillus sp. JS12	1.10.3.2	concentration	2,6-Dimethoxyphenol			-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	70.0	6.5	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	Km	Guaiacol	0.0035299999999999997		5.9E-4	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	concentration	Guaiacol			-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	Vmax				-	-	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	kcat/Km	Guaiacol	10990.0		-	M^(-1)*s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	concentration	Cu2+	1.0E-4		-	M	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69992	O2 + Guaiacol = H2O + Oxidized guaiacol	Geobacillus sp. JS12	1.10.3.2	kcat		38.81		2.97	s^(-1)	A0A142CZ78	wildtype LacG, C-terminal His-tag	laccase	Jeon SJ, Park JH: Refolding, characterization, and dye decolorization ability of a highly thermostable laccase from Geobacillus sp. JS12, Protein Expr Purif 2020 (173) , 105646	32315700	O2;Guaiacol	H2O;Oxidized guaiacol	70.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	concentration	Enzyme	0.4		-	mg/ml	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	Vmax		5.208333333333333E-4		-	mol*s^(-1)*g^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	kcat		37.5		-	s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	Km	Guaiacol	0.0017490000000000001		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	concentration	Cu2+	4.9999999999999996E-5		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	concentration	Guaiacol			-	-	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69998	O2 + Guaiacol = H2O + Oxidized guaiacol	Acinetobacter baumannii	1.10.3.2	kcat/Km	Guaiacol	20000.0		-	M^(-1)*s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	Guaiacol;O2	Oxidized guaiacol;H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	150000.0		-	M^(-1)*s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	concentration	Cu2+	4.9999999999999996E-5		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	Vmax		0.004166666666666667		-	mol*s^(-1)*g^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	concentration	Enzyme	0.4		-	mg/ml	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	0.001987		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
69999	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Acinetobacter baumannii	1.10.3.2	kcat		300.0		-	s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	Enzyme	0.4		-	mg/ml	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	Vmax		1.95E-4		-	mol*s^(-1)*g^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	kcat		14.0		-	s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	kcat/Km	Catechol	10000.0		-	M^(-1)*s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	Cu2+	4.9999999999999996E-5		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	Km	Catechol	8.8E-4		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70000	O2 + Catechol = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	Catechol			-	-	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;Catechol	H2O;Oxidized donor	50.0	6.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	kcat/Km	1,2,3-Trihydroxybenzene	180000.0		-	M^(-1)*s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	kcat		20.0		-	s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	Vmax		2.766666666666667E-4		-	mol*s^(-1)*g^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	Km	1,2,3-Trihydroxybenzene	1.1E-4		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	concentration	Cu2+	4.9999999999999996E-5		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	concentration	1,2,3-Trihydroxybenzene			-	-	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70001	O2 + 1,2,3-Trihydroxybenzene = H2O + Oxidized pyrogallol	Acinetobacter baumannii	1.10.3.2	concentration	Enzyme	0.4		-	mg/ml	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;1,2,3-Trihydroxybenzene	Oxidized pyrogallol;H2O	50.0	8.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	Vmax		9.803333333333335E-4		-	mol*s^(-1)*g^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	Km	2,3-Dihydroxybenzoate	8.85E-4		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	kcat/Km	2,3-Dihydroxybenzoate	80000.0		-	M^(-1)*s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	Enzyme	0.4		-	mg/ml	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	kcat		70.56		-	s^(-1)	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	2,3-Dihydroxybenzoate			-	-	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70002	O2 + 2,3-Dihydroxybenzoate = H2O + Oxidized donor	Acinetobacter baumannii	1.10.3.2	concentration	Cu2+	4.9999999999999996E-5		-	M	D0C997	wildtype	laccase	Kaur K, Sidhu H, Capalash N, Sharma P: Multicopper oxidase of Acinetobacter baumannii: Assessing its role in metal homeostasis, stress management and virulence, Microb Pathog 2020 (143) , 104124	32169492	O2;2,3-Dihydroxybenzoate	Oxidized donor;H2O	50.0	7.0	Vmax*S/(Km+S)
70012	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.0E-5	5.0E-4	-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70012	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70012	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		40.26		-	s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70012	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.41E-4		-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70012	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	167050.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70013	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.7199999999999998E-4		-	M	A0A0G2QNK1	mutant S208G N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70013	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	223600.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant S208G N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70013	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		38.46		-	s^(-1)	A0A0G2QNK1	mutant S208G N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70013	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant S208G N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70013	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.0E-5	5.0E-4	-	M	A0A0G2QNK1	mutant S208G N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70014	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.23E-4		-	M	A0A0G2QNK1	mutant F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.5	kcat*E*S/(Km+S)
70014	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.5	kcat*E*S/(Km+S)
70014	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.0E-5	5.0E-4	-	M	A0A0G2QNK1	mutant F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.5	kcat*E*S/(Km+S)
70014	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		43.44		-	s^(-1)	A0A0G2QNK1	mutant F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.5	kcat*E*S/(Km+S)
70014	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	353170.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.5	kcat*E*S/(Km+S)
70015	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	856970.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70015	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70015	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	7.3E-5		-	M	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70015	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		56.52		-	s^(-1)	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70015	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.0E-5	5.0E-4	-	M	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Wang HR, Wang YJ, Xia J, Ma H, Cai YJ, Liao XR, Guan ZB: Enhancement in catalytic activity of CotA-laccase from Bacillus pumilus W3 via site-directed mutagenesis, J Biosci Bioeng 2020 (129) , 405-411	31672431	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.5	kcat*E*S/(Km+S)
70026	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	4.9999999999999996E-6	0.001	-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	22.0	4.2	(E*kcat)*S/(Km+S)
70026	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	kcat		9.4		-	s^(-1)		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	22.0	4.2	(E*kcat)*S/(Km+S)
70026	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	3.4899999999999995E-5		-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	22.0	4.2	(E*kcat)*S/(Km+S)
70026	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus licheniformis	1.10.3.2	concentration	Enzyme			-	-		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	22.0	4.2	(E*kcat)*S/(Km+S)
70027	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus licheniformis	1.10.3.2	Km	Syringaldazine	8.3E-6		-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	Syringaldazine;O2	Oxidized syringaldazine;H2O	22.0	6.8	(E*kcat)*S/(Km+S)
70027	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus licheniformis	1.10.3.2	kcat		2.7		-	s^(-1)		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	Syringaldazine;O2	Oxidized syringaldazine;H2O	22.0	6.8	(E*kcat)*S/(Km+S)
70027	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus licheniformis	1.10.3.2	concentration	Enzyme			-	-		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	Syringaldazine;O2	Oxidized syringaldazine;H2O	22.0	6.8	(E*kcat)*S/(Km+S)
70027	O2 + Syringaldazine = Oxidized syringaldazine + H2O	Bacillus licheniformis	1.10.3.2	concentration	Syringaldazine	1.0E-6	9.999999999999999E-5	-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	Syringaldazine;O2	Oxidized syringaldazine;H2O	22.0	6.8	(E*kcat)*S/(Km+S)
70028	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	concentration	2,6-Dimethoxyphenol	9.999999999999999E-6	0.002	-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	22.0	7.2	(E*kcat)*S/(Km+S)
70028	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	concentration	Enzyme			-	-		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	22.0	7.2	(E*kcat)*S/(Km+S)
70028	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	Km	2,6-Dimethoxyphenol	7.79E-5		-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	22.0	7.2	(E*kcat)*S/(Km+S)
70028	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Bacillus licheniformis	1.10.3.2	kcat		0.9		-	s^(-1)		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	2,6-Dimethoxyphenol;O2	Oxidized donor;H2O	22.0	7.2	(E*kcat)*S/(Km+S)
70029	O2 + Aflatoxin B1 = H2O + Oxidized donor	Bacillus licheniformis	1.10.3.2	concentration	Enzyme	0.02		-	mg/ml		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	O2;Aflatoxin B1	H2O;Oxidized donor	37.0	8.0	Vmax*S/(Km+S)
70029	O2 + Aflatoxin B1 = H2O + Oxidized donor	Bacillus licheniformis	1.10.3.2	Km	Aflatoxin B1	6.061999999999999E-5		-	M		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	O2;Aflatoxin B1	H2O;Oxidized donor	37.0	8.0	Vmax*S/(Km+S)
70029	O2 + Aflatoxin B1 = H2O + Oxidized donor	Bacillus licheniformis	1.10.3.2	kcat		0.03		-	s^(-1)		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	O2;Aflatoxin B1	H2O;Oxidized donor	37.0	8.0	Vmax*S/(Km+S)
70029	O2 + Aflatoxin B1 = H2O + Oxidized donor	Bacillus licheniformis	1.10.3.2	concentration	Aflatoxin B1	0.001	0.1	-	mg/ml		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	O2;Aflatoxin B1	H2O;Oxidized donor	37.0	8.0	Vmax*S/(Km+S)
70029	O2 + Aflatoxin B1 = H2O + Oxidized donor	Bacillus licheniformis	1.10.3.2	Vmax		1.6800000000000002E-4		-	g/(s*g)		wildtype C-terminal His-tag	laccase	Guo Y, Qin X, Tang Y, Ma Q, Zhang J, Zhao L: CotA laccase, a novel aflatoxin oxidase from Bacillus licheniformis, transforms aflatoxin B<sub>1</sub> to aflatoxin Q<sub>1</sub> and epi-aflatoxin Q<sub>1</sub>, Food Chem 2020 (325) , 126877	32387986	O2;Aflatoxin B1	H2O;Oxidized donor	37.0	8.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	Km	Malachite green	0.0396		-	M	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	kcat		18.36		-	s^(-1)	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	3.0E-4		-	M	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	concentration	Enzyme	8.3335E-5		-	katal*l^(-1)	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	Vmax		1.194E-5		-	M*s^(-1)	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70052	O2 + Malachite green = 4-(Dimethylamino)phenol + 4-(Dimethylamino)benzophenone	Bacillus pumilus	1.10.3.2	concentration	Malachite green	0.022	0.225	-	mg/ml	A0A0G2QNK1	mutant S208G/F227A N-terminal His6-tag	laccase	Xu KZ, Ma H, Wang YJ, Cai YJ, Liao XR, Guan ZB: Extracellular expression of mutant CotA-laccase SF in Escherichia coli and its degradation of malachite green, Ecotoxicol Environ Saf 2020 (193) , 110335	32088549	Malachite green;O2	4-(Dimethylamino)phenol;4-(Dimethylamino)benzophenone	25.0	7.0	Vmax*S/(Km+S)
70072	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Staphylococcus haemolyticus	1.10.3.2	kcat		6.87		-	s^(-1)	L7SV51	wildtype His-tag	laccase	Li X, Liu D, Wu Z, Li D, Cai Y, Lu Y, Zhao X, Xue H: Multiple Tolerance and Dye Decolorization Ability of a Novel Laccase Identified from <i>Staphylococcus Haemolyticus</i>, J Microbiol Biotechnol 2020 (30) , 615-621	31986565	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.5	kcat*E*S/(Km+S)
70072	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Staphylococcus haemolyticus	1.10.3.2	concentration	Enzyme	0.00521		-	mg/ml	L7SV51	wildtype His-tag	laccase	Li X, Liu D, Wu Z, Li D, Cai Y, Lu Y, Zhao X, Xue H: Multiple Tolerance and Dye Decolorization Ability of a Novel Laccase Identified from <i>Staphylococcus Haemolyticus</i>, J Microbiol Biotechnol 2020 (30) , 615-621	31986565	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.5	kcat*E*S/(Km+S)
70072	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Staphylococcus haemolyticus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.398E-4		-	M	L7SV51	wildtype His-tag	laccase	Li X, Liu D, Wu Z, Li D, Cai Y, Lu Y, Zhao X, Xue H: Multiple Tolerance and Dye Decolorization Ability of a Novel Laccase Identified from <i>Staphylococcus Haemolyticus</i>, J Microbiol Biotechnol 2020 (30) , 615-621	31986565	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.5	kcat*E*S/(Km+S)
70072	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Staphylococcus haemolyticus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	4.9999999999999996E-5	0.001	-	M	L7SV51	wildtype His-tag	laccase	Li X, Liu D, Wu Z, Li D, Cai Y, Lu Y, Zhao X, Xue H: Multiple Tolerance and Dye Decolorization Ability of a Novel Laccase Identified from <i>Staphylococcus Haemolyticus</i>, J Microbiol Biotechnol 2020 (30) , 615-621	31986565	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	30.0	4.5	kcat*E*S/(Km+S)
70167	O2 + Potassium ferrocyanide = H2O + Potassium ferricyanide	Streptomyces californicus	1.10.3.2	concentration	Potassium ferrocyanide			-	-	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Potassium ferrocyanide;O2	Potassium ferricyanide;H2O	30.0	4.0	(E*kcat)*S/(Km+S)
70167	O2 + Potassium ferrocyanide = H2O + Potassium ferricyanide	Streptomyces californicus	1.10.3.2	kcat/Km	Potassium ferrocyanide	44800.0		-	M^(-1)*s^(-1)	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Potassium ferrocyanide;O2	Potassium ferricyanide;H2O	30.0	4.0	(E*kcat)*S/(Km+S)
70167	O2 + Potassium ferrocyanide = H2O + Potassium ferricyanide	Streptomyces californicus	1.10.3.2	Km	Potassium ferrocyanide	8.7E-4		4.0E-5	M	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Potassium ferrocyanide;O2	Potassium ferricyanide;H2O	30.0	4.0	(E*kcat)*S/(Km+S)
70167	O2 + Potassium ferrocyanide = H2O + Potassium ferricyanide	Streptomyces californicus	1.10.3.2	kcat		39.0		0.7	s^(-1)	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Potassium ferrocyanide;O2	Potassium ferricyanide;H2O	30.0	4.0	(E*kcat)*S/(Km+S)
70167	O2 + Potassium ferrocyanide = H2O + Potassium ferricyanide	Streptomyces californicus	1.10.3.2	concentration	Enzyme			-	-	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Potassium ferrocyanide;O2	Potassium ferricyanide;H2O	30.0	4.0	(E*kcat)*S/(Km+S)
70168	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Streptomyces californicus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)			-	-	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	30.0	4.0	(E*kcat)*S/(Km+S)
70168	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Streptomyces californicus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	65600.0		-	M^(-1)*s^(-1)	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	30.0	4.0	(E*kcat)*S/(Km+S)
70168	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Streptomyces californicus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	3.7E-4		2.1000000000000002E-5	M	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	30.0	4.0	(E*kcat)*S/(Km+S)
70168	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Streptomyces californicus	1.10.3.2	concentration	Enzyme			-	-	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	30.0	4.0	(E*kcat)*S/(Km+S)
70168	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Streptomyces californicus	1.10.3.2	kcat		24.3		0.26	s^(-1)	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	30.0	4.0	(E*kcat)*S/(Km+S)
70169	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Streptomyces californicus	1.10.3.2	Km	2,6-Dimethoxyphenol	0.00115		1.0E-4	M	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	30.0	8.5	(E*kcat)*S/(Km+S)
70169	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Streptomyces californicus	1.10.3.2	kcat		3.4		0.064	s^(-1)	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	30.0	8.5	(E*kcat)*S/(Km+S)
70169	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Streptomyces californicus	1.10.3.2	kcat/Km	2,6-Dimethoxyphenol	2950.0		-	M^(-1)*s^(-1)	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	30.0	8.5	(E*kcat)*S/(Km+S)
70169	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Streptomyces californicus	1.10.3.2	concentration	2,6-Dimethoxyphenol			-	-	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	30.0	8.5	(E*kcat)*S/(Km+S)
70169	O2 + 2,6-Dimethoxyphenol = Oxidized donor + H2O	Streptomyces californicus	1.10.3.2	concentration	Enzyme			-	-	A0A1G6NPX3;A0A6G2W9K1;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	O2;2,6-Dimethoxyphenol	H2O;Oxidized donor	30.0	8.5	(E*kcat)*S/(Km+S)
70170	O2 + Guaiacol = H2O + Oxidized guaiacol	Streptomyces californicus	1.10.3.2	Km	Guaiacol	0.0057		2.5E-4	M	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Guaiacol;O2	Oxidized guaiacol;H2O	30.0	8.5	(E*kcat)*S/(Km+S)
70170	O2 + Guaiacol = H2O + Oxidized guaiacol	Streptomyces californicus	1.10.3.2	concentration	Enzyme			-	-	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Guaiacol;O2	Oxidized guaiacol;H2O	30.0	8.5	(E*kcat)*S/(Km+S)
70170	O2 + Guaiacol = H2O + Oxidized guaiacol	Streptomyces californicus	1.10.3.2	concentration	Guaiacol			-	-	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Guaiacol;O2	Oxidized guaiacol;H2O	30.0	8.5	(E*kcat)*S/(Km+S)
70170	O2 + Guaiacol = H2O + Oxidized guaiacol	Streptomyces californicus	1.10.3.2	kcat/Km	Guaiacol	150.0		-	M^(-1)*s^(-1)	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Guaiacol;O2	Oxidized guaiacol;H2O	30.0	8.5	(E*kcat)*S/(Km+S)
70170	O2 + Guaiacol = H2O + Oxidized guaiacol	Streptomyces californicus	1.10.3.2	kcat		0.85		0.03	s^(-1)	A0A6G2W9K1;A0A1G6NPX3;A0A6G2W9K1;A0A1G6NPX3	wildtype SpSL, His-tagged	laccase	Trubitsina LI, Lisov AV, Belova OV, Trubitsin IV, Demin VV, Konstantinov AI, Zavarzina AG, Leontievsky AA: Transformation of low molecular compounds and soil humic acid by two domain laccase of Streptomyces puniceus in the presence of ferulic and caffeic acids, PLoS One 2020 (15) , 0239005	32946485	Guaiacol;O2	Oxidized guaiacol;H2O	30.0	8.5	(E*kcat)*S/(Km+S)
70222	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	Enzyme	0.002		-	mg/ml	Q8ZWA8	wildtype N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70222	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.0E-5	0.00128	-	M	Q8ZWA8	wildtype N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70222	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	kcat		1.82		0.08	s^(-1)	Q8ZWA8	wildtype N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70222	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.02E-4		5.299999999999999E-6	M	Q8ZWA8	wildtype N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70223	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.0E-5	0.00128	-	M	Q8ZWA8	mutant M470L N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70223	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	kcat		2.18		0.03	s^(-1)	Q8ZWA8	mutant M470L N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70223	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	3.2E-5		3.0E-6	M	Q8ZWA8	mutant M470L N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70223	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	Enzyme	0.002		-	mg/ml	Q8ZWA8	mutant M470L N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.0	(E*kcat)*S/(Km+S)
70224	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	Enzyme	0.002		-	mg/ml	Q8ZWA8	mutant M470F N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.0	(E*kcat)*S/(Km+S)
70224	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	kcat		2.4		0.12	s^(-1)	Q8ZWA8	mutant M470F N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.0	(E*kcat)*S/(Km+S)
70224	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	6.24E-5		4.7E-6	M	Q8ZWA8	mutant M470F N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.0	(E*kcat)*S/(Km+S)
70224	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Pyrobaculum aerophilum	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.0E-5	0.00128	-	M	Q8ZWA8	mutant M470F N-terminal His-tagged	laccase	Takamura E, Taki S, Sakamoto H, Satomura T, Sakuraba H, Ohshima T, Suye SI: Site-Directed Mutagenesis of Multicopper Oxidase from Hyperthermophilic Archaea for High-Voltage Biofuel Cells, Appl Biochem Biotechnol 2020 (193) , xxx	33025566	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.0	(E*kcat)*S/(Km+S)
70225	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.53E-4		-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70225	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	158540.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70225	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70225	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		40.11		-	s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70225	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70226	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70226	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70226	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.2700000000000002E-4		-	M	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70226	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		50.66		-	s^(-1)	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70226	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	223170.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70227	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70227	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		85.0		-	s^(-1)	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70227	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	325660.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70227	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70227	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	2.61E-4		-	M	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70228	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70228	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70228	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	388430.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70228	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		54.38		-	s^(-1)	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70228	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.4000000000000001E-4		-	M	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70229	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70229	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	356730.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70229	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		36.03		-	s^(-1)	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70229	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.01E-4		-	M	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70229	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);H2O	50.0	3.6	kcat*E*S/(Km+S)
70230	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	1.09E-4		-	M	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70230	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	9.999999999999999E-6	0.001	-	M	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70230	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat/Km	2,2''-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	845500.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70230	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	kcat		92.16		-	s^(-1)	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70230	O2 + 2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) = Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) + H2O	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	2,2'-Azino-bis(3-ethylbenzthiazoline-6-sulfonic acid);O2	H2O;Oxidized 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid)	50.0	3.6	kcat*E*S/(Km+S)
70231	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70231	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70231	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	5.19E-4		-	M	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70231	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		3.63		-	s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70231	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	6990.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	wildtype N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70232	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	4.4300000000000003E-4		-	M	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70232	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70232	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	10070.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70232	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		4.46		-	s^(-1)	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70232	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T415D N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70233	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		4.81		-	s^(-1)	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70233	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	11230.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70233	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70233	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	4.28E-4		-	M	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70233	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T418K N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70234	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	17740.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70234	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70234	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	3.23E-4		-	M	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70234	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70234	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		5.73		-	s^(-1)	A0A0G2QNK1	mutant Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70235	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70235	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		5.56		-	s^(-1)	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70235	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	2.98E-4		-	M	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70235	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70235	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	18670.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T415D/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	O2;Reactive black 5	H2O;Oxidized reactive black 5	37.0	10.0	kcat*E*S/(Km+S)
70236	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Reactive black 5	2.4999999999999998E-5	3.0E-4	-	M	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70236	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	concentration	Enzyme			-	-	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70236	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	Km	Reactive black 5	2.12E-4		-	M	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70236	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat		4.78		-	s^(-1)	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70236	O2 + Reactive black 5 = H2O + Oxidized reactive black 5	Bacillus pumilus	1.10.3.2	kcat/Km	Reactive black 5	22540.0		-	M^(-1)*s^(-1)	A0A0G2QNK1	mutant T418K/Q442A N-terminal His6-tag	laccase	Ma H, Xu KZ, Wang YJ, Yan N, Liao XR, Guan ZB: Enhancing the decolorization activity of Bacillus pumilus W3 CotA-laccase to Reactive Black 5 by site- saturation mutagenesis, Appl Microbiol Biotechnol 2020 (104) , 9193-9204	32918582	Reactive black 5;O2	Oxidized reactive black 5;H2O	37.0	10.0	kcat*E*S/(Km+S)
70286	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	3.0085000000000005E-7		1.4150000000000001E-8	M	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70286	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70286	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70287	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70287	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70287	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-PEG4-Chol	4.2700000000000005E-8		5.4E-9	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70288	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70288	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70288	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-PEG4-Palm	6.920000000000001E-8		-	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70289	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70289	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70289	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-Chol	5.68E-8		-	M	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70290	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSG-Chol	4.820000000000001E-8		-	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70290	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70290	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70291	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70291	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSG-PEG4-Chol	1.06E-8		-	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70291	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70292	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70292	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70292	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	1.3E-9		-	M	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70293	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70293	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG8-Chol	3.1000000000000005E-9		-	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70293	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70294	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG12-Chol	3.9E-9		-	M	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70294	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70294	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	Q9BYF1;P0DTC2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70295	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG24-Chol	3.9E-9		-	M	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70295	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	ACE2			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70295	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS-CoV-2	-	concentration	Spike glycoprotein			-	-	P0DTC2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70296	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P59594	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70296	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	concentration	ACE2			-	-	Q9BYF1;P59594	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70296	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	4.0930000000000005E-7		-	M	Q9BYF1;P59594	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70297	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	4.3000000000000005E-9		-	M	P59594;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70297	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	concentration	ACE2			-	-	P59594;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70297	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	SARS coronavirus	-	concentration	Spike glycoprotein			-	-	P59594;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70298	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	Spike glycoprotein			-	-	Q9BYF1;R9UQ53	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70298	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	ACE2			-	-	Q9BYF1;R9UQ53	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70298	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	2.395E-7		-	M	Q9BYF1;R9UQ53	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70299	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	ACE2			-	-	R9UQ53;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70299	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	2.5E-9		-	M	R9UQ53;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70299	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Middle East respiratory syndrome-related coronavirus	-	concentration	Spike glycoprotein			-	-	R9UQ53;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70300	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	concentration	ACE2			-	-	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70300	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70300	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	7.876000000000001E-7		-	M	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70301	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	7.700000000000001E-9		-	M	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70301	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70301	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus OC43	-	concentration	ACE2			-	-	Q9BYF1;P36334	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70302	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	2.0740000000000002E-7		-	M	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70302	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70302	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	concentration	ACE2			-	-	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70303	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	concentration	ACE2			-	-	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70303	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	concentration	Spike glycoprotein			-	-	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70303	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus 229E	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	5.2E-9		-	M	Q9BYF1;P15423	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70304	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	7.510000000000001E-7		-	M	Q6Q1S2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70304	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	concentration	Spike glycoprotein			-	-	Q6Q1S2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70304	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	concentration	ACE2			-	-	Q6Q1S2;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70305	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	concentration	Spike glycoprotein			-	-	Q9BYF1;Q6Q1S2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70305	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	2.14E-8		-	M	Q9BYF1;Q6Q1S2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70305	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Human coronavirus NL63	-	concentration	ACE2			-	-	Q9BYF1;Q6Q1S2	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70306	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	concentration	Spike glycoprotein			-	-	Q9BYF1;U5WI05	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70306	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	2.657E-7		-	M	Q9BYF1;U5WI05	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70306	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	concentration	ACE2			-	-	Q9BYF1;U5WI05	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70307	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	4.500000000000001E-9		-	M	U5WI05;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70307	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	concentration	Spike glycoprotein			-	-	U5WI05;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70307	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus WIV1	-	concentration	ACE2			-	-	U5WI05;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70308	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	2.3700000000000002E-7		-	M	U5WHZ7;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70308	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	concentration	ACE2			-	-	U5WHZ7;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70308	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	concentration	Spike glycoprotein			-	-	U5WHZ7;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70309	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	concentration	Spike glycoprotein			-	-	Q9BYF1;U5WHZ7	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70309	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	8.1E-9		-	M	Q9BYF1;U5WHZ7	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70309	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus Rs3367	-	concentration	ACE2			-	-	Q9BYF1;U5WHZ7	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	ACE2;Spike glycoprotein	Spike glycoprotein-ACE2 complex	37.0	-	-
70310	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	concentration	ACE2			-	-	Q9BYF1;U5WLK5	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70310	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL	2.7960000000000004E-7		-	M	Q9BYF1;U5WLK5	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70310	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	concentration	Spike glycoprotein			-	-	Q9BYF1;U5WLK5	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70311	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	IC50	SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL-GSGSG-PEG4-Chol	4.3000000000000005E-9		-	M	U5WLK5;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70311	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	concentration	Spike glycoprotein			-	-	U5WLK5;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70311	ACE2 + Spike glycoprotein = Spike glycoprotein-ACE2 complex	Bat SARS-like coronavirus RsSHC014	-	concentration	ACE2			-	-	U5WLK5;Q9BYF1	wildtype		Xia S, Liu M, Wang C, Xu W, Lan Q, Feng S, Qi F, Bao L, Du L, Liu S, Qin C, Sun F, Shi Z, Zhu Y, Jiang S, Lu L: Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion, Cell Res 2020 (30) , 343-355	32231345	Spike glycoprotein;ACE2	Spike glycoprotein-ACE2 complex	37.0	-	-
70670	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	9-O-Demethyltrigonostemone	2.2E-7		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70670	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	1.67E-5		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70670	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70671	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70671	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	Shikonin	9.799999999999999E-8		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70671	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	1.67E-5		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70672	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70672	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	1.67E-5		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70672	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	Dihydrotanshinone I	2.7999999999999997E-7		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70673	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	INCB024360	1.1E-8		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70673	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	1.67E-5		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70673	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70674	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	9-O-Demethyltrigonostemone	1.8399999999999997E-6		-	M	P14902	wildtype	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70675	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	Shikonin	2.2E-7		-	M	P14902	wildtype	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70676	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	IC50	Dihydrotanshinone I	2.57E-6		-	M	P14902	wildtype	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70677	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	7.5E-7	3.0E-6	-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70677	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	Ki	9-O-Demethyltrigonostemone	6.9E-7		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70677	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70678	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70678	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	Ki	Shikonin	1.3999999999999998E-7		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70678	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	7.5E-7	3.0E-6	-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70679	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	Enzyme	1.7000000000000001E-9		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70679	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	concentration	L-Tryptophan	7.5E-7	3.0E-6	-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70679	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.52	Ki	Dihydrotanshinone I	2.7999999999999997E-7		-	M	P14902	wildtype His-tagged	 indoleamine 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70680	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	L-Tryptophan	1.67E-5		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70680	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	Enzyme	1.7000000000000001E-9		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70680	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	9-O-Demethyltrigonostemone	9.11E-6		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70681	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	Enzyme	1.7000000000000001E-9		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70681	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	Dihydrotanshinone I	5.1E-7		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70681	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	L-Tryptophan	1.67E-5		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70682	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	L-Tryptophan	1.67E-5		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70682	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	concentration	Enzyme	1.7000000000000001E-9		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70682	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	Shikonin	5.049999999999999E-7		-	M	P48775	wildtype His-tagged	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70683	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	9-O-Demethyltrigonostemone	2.4699999999999996E-6		-	M	P48775	wildtype	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	O2;L-Tryptophan	L-Formylkynurenine	37.0	6.5	-
70684	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	Shikonin	1.3999999999999998E-7		-	M	P48775	wildtype	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70685	L-Tryptophan + O2 = L-Formylkynurenine	Homo sapiens	1.13.11.11	IC50	Dihydrotanshinone I	1.33E-6		-	M	P48775	wildtype	tryptophan 2,3-dioxygenase	Guo W, Yao S, Sun P, Yang TB, Tang CP, Zheng MY, Ye Y, Meng LH: Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Acta Pharmacol Sin 2020 (41) , 423-431	31197246	L-Tryptophan;O2	L-Formylkynurenine	37.0	6.5	-
70705	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	3.0000000000000004E-9		-	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70705	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	N-((S)-3-Cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl)-1H-indole-2-carboxamide			-	-	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70705	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	IC50	N-((S)-3-Cyclohexyl-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl)-1H-indole-2-carboxamide	5.2999999999999995E-9		5.0E-10	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70705	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	2.0E-6		-	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70706	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	2.0E-6		-	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70706	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	N-((S)-3-(3-Fluorophenyl)-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl)-1H-indole-2-carboxamide			-	-	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70706	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	IC50	N-((S)-3-(3-Fluorophenyl)-1-oxo-1-(((S)-1-oxo-3-((S)-2-oxopyrrolidin-3-yl)propan-2-yl)amino)propan-2-yl)-1H-indole-2-carboxamide	4.0E-9		2.0E-10	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70706	H2O + MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2 = SGFR-Lys(Dnp)-Lys-NH2 + MCA-AVLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	3.0000000000000004E-9		-	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3264-3569)	SARS coronavirus main proteinase	Dai W, Zhang B, Jiang XM, Su H, Li J, Zhao Y, Xie X, Jin Z, Peng J, Liu F, Li C, Li Y, Bai F, Wang H, Cheng X, Cen X, Hu S, Yang X, Wang J, Liu X, Xiao G, Jiang H, Rao Z, Zhang LK, Xu Y, Yang H, Liu H: Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease, Science 2020 (368) , 1331-1335	32321856	H2O;MCA-AVLQSGFR-Lys(Dnp)-Lys-NH2	SGFR-Lys(Dnp)-Lys-NH2;MCA-AVLQ	30.0	7.3	-
70979	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	IC50	Boceprevir	2.7E-7		5.0E-9	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70979	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	2.0000000000000004E-8		-	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70979	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70979	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0DTC1;P0DTD1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70980	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70980	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70980	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	concentration	Enzyme	2.0000000000000004E-8		-	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70980	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS-CoV-2	3.4.22.69	IC50	Telaprevir	1.07E-6		4.0E-8	M	P0DTD1;P0DTC1	wildtype 3CLpro (aa 3259-3569), N-terminal His-tag	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70981	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS-CoV-2	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	P0DTD1;P0DTC1	wildtype PLpro Ubl2 (aa 1564-1874)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70981	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS-CoV-2	3.4.22.n14	IC50	Asunaprevir	5.389999999999999E-6		2.1E-7	M	P0DTD1;P0DTC1	wildtype PLpro Ubl2 (aa 1564-1874)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70981	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS-CoV-2	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	P0DTD1;P0DTC1	wildtype PLpro Ubl2 (aa 1564-1874)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70981	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS-CoV-2	3.4.22.n14	concentration	Enzyme	1.4000000000000001E-8		-	M	P0DTD1;P0DTC1	wildtype PLpro Ubl2 (aa 1564-1874)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70982	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6U8;P0C6X7	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70982	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0C6U8;P0C6X7	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70982	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	IC50	Boceprevir	2.5E-7		8.0E-9	M	P0C6U8;P0C6X7	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70982	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	Enzyme	2.5000000000000005E-8		-	M	P0C6U8;P0C6X7	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70983	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	Enzyme	2.5000000000000005E-8		-	M	P0C6X7;P0C6U8	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70983	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0C6X7;P0C6U8	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70983	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	IC50	Telaprevir	1.07E-6		5.0E-8	M	P0C6X7;P0C6U8	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70983	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	SARS coronavirus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6X7;P0C6U8	wildtype 3CLpro (aa 3241-3546)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70984	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS coronavirus	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	P0C6X7;P0C6U8	wildtype PLpro (aa 1541-1855)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70984	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS coronavirus	3.4.22.n14	concentration	Enzyme	1.4000000000000001E-8		-	M	P0C6X7;P0C6U8	wildtype PLpro (aa 1541-1855)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70984	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS coronavirus	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	P0C6X7;P0C6U8	wildtype PLpro (aa 1541-1855)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70984	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	SARS coronavirus	3.4.22.n14	IC50	Asunaprevir	4.779999999999999E-6		2.2999999999999997E-7	M	P0C6X7;P0C6U8	wildtype PLpro (aa 1541-1855)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70985	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Middle East respiratory syndrome-related coronavirus	3.4.22.69	IC50	Boceprevir	3.7999999999999996E-7		4.0E-8	M	K9N7C7;K9N638	wildtype 3CLpro (aa 3248-3553)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70985	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Middle East respiratory syndrome-related coronavirus	3.4.22.69	Activation constant	Boceprevir	2.3000000000000004E-8		3.0000000000000004E-9	M	K9N7C7;K9N638	wildtype 3CLpro (aa 3248-3553)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70985	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Middle East respiratory syndrome-related coronavirus	3.4.22.69	concentration	Enzyme	1.0E-7		-	M	K9N7C7;K9N638	wildtype 3CLpro (aa 3248-3553)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70985	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Middle East respiratory syndrome-related coronavirus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	K9N7C7;K9N638	wildtype 3CLpro (aa 3248-3553)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70985	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Middle East respiratory syndrome-related coronavirus	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	K9N7C7;K9N638	wildtype 3CLpro (aa 3248-3553)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70986	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Middle East respiratory syndrome-related coronavirus	3.4.22.n14	IC50	Asunaprevir	4.18E-6		7.4E-7	M	K9N7C7;K9N638	wildtype PLpro (aa 1484-1802)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70986	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Middle East respiratory syndrome-related coronavirus	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	K9N7C7;K9N638	wildtype PLpro (aa 1484-1802)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70986	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Middle East respiratory syndrome-related coronavirus	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	K9N7C7;K9N638	wildtype PLpro (aa 1484-1802)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70986	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Middle East respiratory syndrome-related coronavirus	3.4.22.n14	concentration	Enzyme	1.0E-7		-	M	K9N7C7;K9N638	wildtype PLpro (aa 1484-1802)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70987	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus HKU1	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6X2;P0C6U3	wildtype 3CLpro (aa 3335-3637)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70987	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus HKU1	3.4.22.69	concentration	Enzyme	1.2500000000000003E-8		-	M	P0C6X2;P0C6U3	wildtype 3CLpro (aa 3335-3637)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70987	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus HKU1	3.4.22.69	IC50	Boceprevir	9.199999999999999E-7		2.1E-7	M	P0C6X2;P0C6U3	wildtype 3CLpro (aa 3335-3637)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70987	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus HKU1	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0C6X2;P0C6U3	wildtype 3CLpro (aa 3335-3637)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70988	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70988	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	IC50	Boceprevir	4.2E-8		1.0E-9	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70988	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70988	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Enzyme	1.0000000000000002E-8		-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70989	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70989	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Enzyme	1.0000000000000002E-8		-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70989	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70989	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Tylonycteris bat coronavirus HKU4	3.4.22.69	IC50	Telaprevir	2.4E-7		2.0E-8	M	P0C6W3;P0C6T4	wildtype 3CLpro (aa 3292-3597)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70990	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6W4;P0C6T5	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70990	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	IC50	Boceprevir	1.2E-7		2.9999999999999996E-9	M	P0C6W4;P0C6T5	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70990	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0C6W4;P0C6T5	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70990	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	Enzyme	1.2500000000000003E-8		-	M	P0C6W4;P0C6T5	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70991	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0C6T5;P0C6W4	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70991	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	Enzyme	1.2500000000000003E-8		-	M	P0C6T5;P0C6W4	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70991	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	IC50	Telaprevir	8.699999999999999E-7		6.999999999999999E-8	M	P0C6T5;P0C6W4	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70991	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Pipistrellus bat coronavirus HKU5	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6T5;P0C6W4	wildtype 3CLpro (aa 3339-3644)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2;H2O	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70992	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus NL63	3.4.22.69	IC50	Telaprevir	1.91E-6		9.0E-8	M	P0C6U6;P0C6X5	wildtype 3CLpro (aa 2940-3242)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70992	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus NL63	3.4.22.69	concentration	Enzyme	2.5000000000000005E-8		-	M	P0C6U6;P0C6X5	wildtype 3CLpro (aa 2940-3242)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70992	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus NL63	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0C6U6;P0C6X5	wildtype 3CLpro (aa 2940-3242)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70992	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Human coronavirus NL63	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6U6;P0C6X5	wildtype 3CLpro (aa 2940-3242)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70993	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Human coronavirus NL63	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	P0C6U6;P0C6X5	wildtype PLP2 (aa 1578-1897)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70993	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Human coronavirus NL63	3.4.22.n14	concentration	Enzyme	1.4000000000000001E-8		-	M	P0C6U6;P0C6X5	wildtype PLP2 (aa 1578-1897)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70993	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Human coronavirus NL63	3.4.22.n14	IC50	Asunaprevir	5.88E-6		2.0E-7	M	P0C6U6;P0C6X5	wildtype PLP2 (aa 1578-1897)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70993	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Human coronavirus NL63	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	P0C6U6;P0C6X5	wildtype PLP2 (aa 1578-1897)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70994	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Feline infectious peritonitis virus	3.4.22.69	IC50	Boceprevir	3.8999999999999997E-7		4.0E-8	M	Q98VG9	wildtype 3CLpro (aa 2904-3205)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70994	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Feline infectious peritonitis virus	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	Q98VG9	wildtype 3CLpro (aa 2904-3205)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70994	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Feline infectious peritonitis virus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	Q98VG9	wildtype 3CLpro (aa 2904-3205)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70994	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Feline infectious peritonitis virus	3.4.22.69	concentration	Enzyme	5.000000000000001E-9		-	M	Q98VG9	wildtype 3CLpro (aa 2904-3205)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70995	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Feline infectious peritonitis virus	3.4.22.n14	concentration	Enzyme	1.0E-7		-	M	Q98VG9	wildtype PLP2 (aa 1558-1794)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70995	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Feline infectious peritonitis virus	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	Q98VG9	wildtype PLP2 (aa 1558-1794)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70995	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Feline infectious peritonitis virus	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	Q98VG9	wildtype PLP2 (aa 1558-1794)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70995	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Feline infectious peritonitis virus	3.4.22.n14	IC50	Asunaprevir	3.11E-6		9.4E-7	M	Q98VG9	wildtype PLP2 (aa 1558-1794)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70996	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	Enzyme	5.000000000000001E-9		-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70996	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	IC50	Boceprevir	2.4E-7		5.0E-9	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70996	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70996	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	Boceprevir	0.0	2.9999999999999997E-5	-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	SGLRKAK-(QXL520)-NH2;(HiLyteFluor488)-ESATLQ	37.0	7.5	-
70997	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	Enzyme	5.000000000000001E-9		-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70997	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	IC50	Telaprevir	3.4799999999999997E-6		2.6E-7	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70997	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	2.0E-7		-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70997	H2O + (HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2 = SGLRKAK-(QXL520)-NH2 + (HiLyteFluor488)-ESATLQ	Avian infectious bronchitis virus	3.4.22.69	concentration	Telaprevir	0.0	2.9999999999999997E-5	-	M	P0C6Y3;P0C6V5	wildtype 3CLpro (aa 2782-3088)	SARS coronavirus main proteinase	Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;(HiLyteFluor488)-ESATLQSGLRKAK-(QXL520)-NH2	(HiLyteFluor488)-ESATLQ;SGLRKAK-(QXL520)-NH2	37.0	7.5	-
70998	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Murine hepatitis virus	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	P0C6X9;P0C6V0	wildtype PLpro (aa 1609-1911)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70998	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Murine hepatitis virus	3.4.22.n14	concentration	Enzyme	1.0E-7		-	M	P0C6X9;P0C6V0	wildtype PLpro (aa 1609-1911)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70998	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Murine hepatitis virus	3.4.22.n14	IC50	Asunaprevir	2.96E-6		1.3999999999999998E-7	M	P0C6X9;P0C6V0	wildtype PLpro (aa 1609-1911)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70998	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Murine hepatitis virus	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	P0C6X9;P0C6V0	wildtype PLpro (aa 1609-1911)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		Z-Arg-Leu-Arg-Gly-Gly-AMC;H2O	NH2Mec;Z-Arg-Leu-Arg-Gly-Gly	-	7.5	-
70999	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Porcine epidemic diarrhea virus	3.4.22.n14	IC50	Asunaprevir	4.9E-6		1.3E-7	M	P0C6Y4;P0C6V6	wildtype PLP2 (aa 1688-1933)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70999	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Porcine epidemic diarrhea virus	3.4.22.n14	concentration	Enzyme	1.4000000000000001E-8		-	M	P0C6Y4;P0C6V6	wildtype PLP2 (aa 1688-1933)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70999	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Porcine epidemic diarrhea virus	3.4.22.n14	concentration	Asunaprevir	0.0	1.9999999999999998E-5	-	M	P0C6Y4;P0C6V6	wildtype PLP2 (aa 1688-1933)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
70999	Z-Arg-Leu-Arg-Gly-Gly-AMC + H2O = Z-Arg-Leu-Arg-Gly-Gly + NH2Mec	Porcine epidemic diarrhea virus	3.4.22.n14	concentration	Z-Arg-Leu-Arg-Gly-Gly-AMC	4.9999999999999996E-6		-	M	P0C6Y4;P0C6V6	wildtype PLP2 (aa 1688-1933)		Anson BJ, Chapman ME, Lendy EK, Pshenychnyi S, Aquila RTD, Satchell KJF, Mesecar AD: Broad-spectrum inhibition of coronavirus main and papain-like proteases by HCV drugs, Res Square 2020 (-) , -		H2O;Z-Arg-Leu-Arg-Gly-Gly-AMC	Z-Arg-Leu-Arg-Gly-Gly;NH2Mec	-	7.5	-
71168	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	Enzyme	0.002		-	mg/ml	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	H2O;t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71168	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	IC50	Camostat mesylate	4.200000000000001E-10		-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	H2O;t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71168	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	1.0E-6		-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	H2O;t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71168	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	Camostat mesylate	5.0E-10	1.0E-5	-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	H2O;t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71169	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	IC50	2-(4-((4-Guanidinobenzoyl)oxy)phenyl)acetic acid methanesulfonate	7.030000000000001E-9		-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide;H2O	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71169	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	Enzyme	0.002		-	mg/ml	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide;H2O	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71169	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	2-(4-((4-Guanidinobenzoyl)oxy)phenyl)acetic acid methanesulfonate	5.0E-10	1.0E-5	-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide;H2O	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71169	H2O + t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide = NH2Mec + t-Butyloxycarbonyl-Gln-Ala-Arg	Homo sapiens	3.4.21	concentration	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide	1.0E-6		-	M	O15393	wildtype TMPRSS2 (aa 106-492), N-terminal His-tag	Serine endopeptidases	Hoffmann M, Hofmann-Winkler H, Smith JC, Krüger N, Sørensen LK, Søgaard OS, Hasselstrøm JB, Winkler M, Hempel T, Raich L, Olsson S, Yamazoe T, Yamatsuta K, Mizuno H, Ludwig S, Noé F, Sheltzer JM, Kjolby M, Pöhlmann S: Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity, bioRxiv 2020 (5) , 2020	32793911	t-Butyloxycarbonyl-Gln-Ala-Arg-4-methylcoumarin-7-ylamide;H2O	NH2Mec;t-Butyloxycarbonyl-Gln-Ala-Arg	22.0	8.0	-
71513	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71513	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71513	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		2.1944444444444445E-5		8.333333333333333E-7	g/(s*g)	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71514	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		6.555555555555556E-5		9.444444444444446E-6	g/(s*g)	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	60.0	8.0	-
71514	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	60.0	8.0	-
71514	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	60.0	8.0	-
71515	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71515	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71515	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		7.666666666666667E-5		1.9444444444444445E-5	g/(s*g)	Q6A0I4	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71516	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		7.500000000000001E-6		1.1111111111111112E-6	g/(s*g)	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71516	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71516	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71517	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	60.0	8.0	-
71517	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	60.0	8.0	-
71517	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		5.1388888888888896E-5		5.833333333333333E-6	g/(s*g)	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	60.0	8.0	-
71518	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	specific enz. activity		5.833333333333334E-5		1.1388888888888888E-5	g/(s*g)	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71518	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71518	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Thermobifida fusca	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	Q6A0I3	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71519	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Ideonella sakaiensis	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	A0A0K8P6T7	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71519	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Ideonella sakaiensis	3.1.1.101	specific enz. activity		2.777777777777778E-7		0.0	g/(s*g)	A0A0K8P6T7	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71519	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Ideonella sakaiensis	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	A0A0K8P6T7	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71520	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	specific enz. activity		1.944444444444445E-6		2.777777777777778E-7	g/(s*g)	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71520	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71520	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	40.0	9.0	-
71521	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	50.0	9.0	-
71521	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	specific enz. activity		5.555555555555556E-7		0.0	g/(s*g)	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	50.0	9.0	-
71521	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	Fusarium vanettenii	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	P00590	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	50.0	9.0	-
71522	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71522	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		4.5E-4		1.944444444444445E-6	g/(s*g)	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71522	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	50.0	8.0	-
71523	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	60.0	8.0	-
71523	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0016591666666666666		8.805555555555556E-5	g/(s*g)	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	60.0	8.0	-
71523	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	60.0	8.0	-
71524	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.002588611111111111		8.055555555555556E-6	g/(s*g)	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71524	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71524	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71525	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		4.727777777777778E-4		5.4444444444444446E-5	g/(s*g)	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	50.0	8.0	-
71525	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	50.0	8.0	-
71525	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	50.0	8.0	-
71526	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71526	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0022736111111111112		1.2583333333333335E-4	g/(s*g)	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71526	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	wildtype C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71527	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71527	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71527	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0016472222222222222		8.611111111111112E-5	g/(s*g)	G9BY57	mutant T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71528	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.001513888888888889		1.4722222222222223E-4	g/(s*g)	G9BY57	mutant Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71528	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71528	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71529	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71529	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0029000000000000002		1.4444444444444446E-4	g/(s*g)	G9BY57	mutant F243I C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71529	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71530	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.002691666666666667		1.5555555555555556E-4	g/(s*g)	G9BY57	mutant F243W C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71530	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71530	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71531	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0023722222222222226		6.388888888888888E-5	g/(s*g)	G9BY57	mutant N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71531	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71531	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71532	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71532	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.002263888888888889		5.0E-5	g/(s*g)	G9BY57	mutant N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71532	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71533	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71533	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71533	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0016444444444444447		6.388888888888888E-5	g/(s*g)	G9BY57	mutant D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71534	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71534	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71534	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0027833333333333334		4.3888888888888894E-4	g/(s*g)	G9BY57	mutant F243I/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71535	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71535	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71535	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0022222222222222222		2.0833333333333335E-4	g/(s*g)	G9BY57	mutant F243W/D238C/S283C C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71536	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71536	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71536	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0019472222222222221		4.166666666666667E-5	g/(s*g)	G9BY57	mutant F243I/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71537	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.002277777777777778		1.0833333333333334E-4	g/(s*g)	G9BY57	mutant F243I/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71537	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71537	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Glycol;Terephthalate	65.0	8.0	-
71538	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		4.277777777777778E-4		5.555555555555556E-5	g/(s*g)	G9BY57	mutant F243I/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71538	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71538	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71539	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243I/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71539	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.002677777777777778		8.055555555555556E-5	g/(s*g)	G9BY57	mutant F243I/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71539	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243I/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71540	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71540	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71540	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.001338888888888889		8.333333333333334E-5	g/(s*g)	G9BY57	mutant F243W/D238C/S283C/T96M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71541	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71541	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0021083333333333336		1.638888888888889E-4	g/(s*g)	G9BY57	mutant F243W/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71541	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W/D238C/S283C/Y127G C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Glycol;Terephthalate	65.0	8.0	-
71542	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		6.361111111111111E-4		5.277777777777778E-5	g/(s*g)	G9BY57	mutant F243W/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71542	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71542	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W/D238C/S283C/N246D C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	Poly(ethylene terephthalate);H2O	Terephthalate;Glycol	65.0	8.0	-
71543	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Enzyme	4.5999999999999996E-10		-	M	G9BY57	mutant F243W/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71543	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	specific enz. activity		0.0023833333333333332		1.25E-4	g/(s*g)	G9BY57	mutant F243W/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
71543	H2O + Poly(ethylene terephthalate) = Glycol + Terephthalate	unknown prokaryotic organism	3.1.1.101	concentration	Poly(ethylene terephthalate)	0.67		-	mg/ml	G9BY57	mutant F243W/D238C/S283C/N246M C-terminal His6-tag	poly(ethylene terephthalate) hydrolase	Tournier V, Topham CM, Gilles A, David B, Folgoas C, Moya-Leclair E, Kamionka E, Desrousseaux ML, Texier H, Gavalda S, Cot M, Guémard E, Dalibey M, Nomme J, Cioci G, Barbe S, Chateau M, André I, Duquesne S, Marty A: An engineered PET depolymerase to break down and recycle plastic bottles, Nature 2020 (580) , 216-219	32269349	H2O;Poly(ethylene terephthalate)	Terephthalate;Glycol	65.0	8.0	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Benzylamine	6.5000000000000004E-6	4.0E-4	-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	Vmax				-	-	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	Km	Benzylamine	1.495E-5		-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	N-(1-(3-Fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide	0.0	1.0000000000000002E-8	-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	Ki	N-(1-(3-Fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide	9.452000000000001E-9		-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72357	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Enzyme	0.0125		-	mg/ml	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;Benzylamine;O2	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72358	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	N-(1-(3-Fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide	1.0E-10	1.0E-6	-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	O2;H2O;Benzylamine	Benzaldehyde;NH3;H2O2	37.0	7.4	-
72358	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	IC50	N-(1-(3-Fluorobenzoyl)-1H-indol-5-yl)pyrazine-2-carboxamide	7.773000000000001E-8		1.0000000000000003E-11	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	O2;H2O;Benzylamine	Benzaldehyde;NH3;H2O2	37.0	7.4	-
72358	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Enzyme	0.0125		-	mg/ml	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	O2;H2O;Benzylamine	Benzaldehyde;NH3;H2O2	37.0	7.4	-
72358	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Benzylamine	1.0E-4		-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	O2;H2O;Benzylamine	Benzaldehyde;NH3;H2O2	37.0	7.4	-
72359	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Enzyme	0.0125		-	mg/ml	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;O2;Benzylamine	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72359	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	IC50	N-(1-(4-Fluorobenzyl)-1H-indol-5-yl)pyrazine-2-carboxamide	1.6548000000000002E-7		8.000000000000001E-12	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;O2;Benzylamine	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72359	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	Benzylamine	1.0E-4		-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;O2;Benzylamine	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72359	O2 + H2O + Benzylamine = NH3 + H2O2 + Benzaldehyde	Homo sapiens	1.4.3.4	concentration	N-(1-(4-Fluorobenzyl)-1H-indol-5-yl)pyrazine-2-carboxamide	1.0E-10	1.0E-6	-	M	P27338	wildtype	monoamine oxidase	Elkamhawy A, Paik S, Kim HJ, Park JH, Londhe AM, Lee K, Pae AN, Park KD, Roh EJ: Discovery of <i>N</i>-(1-(3-fluorobenzoyl)-1<i>H</i>-indol-5-yl)pyrazine-2-carboxamide: a novel, selective, and competitive indole-based lead inhibitor for human monoamine oxidase B, J Enzyme Inhib Med Chem 2020 (35) , 1568-1580	32752896	H2O;O2;Benzylamine	NH3;H2O2;Benzaldehyde	37.0	7.4	-
72515	O2 + L-Dopa = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	kcat		10.677		0.274	s^(-1)		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;L-Dopa	H2O;L-Dopaquinone	25.0	7.0	kcat*E*S/(Km+S)
72515	O2 + L-Dopa = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	Km	L-Dopa	4.1E-5		4.000000000000001E-6	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;L-Dopa	H2O;L-Dopaquinone	25.0	7.0	kcat*E*S/(Km+S)
72515	O2 + L-Dopa = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	Enzyme			-	-		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;L-Dopa	H2O;L-Dopaquinone	25.0	7.0	kcat*E*S/(Km+S)
72515	O2 + L-Dopa = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	O2	2.6000000000000002E-5		-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;L-Dopa	H2O;L-Dopaquinone	25.0	7.0	kcat*E*S/(Km+S)
72515	O2 + L-Dopa = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	L-Dopa	0.0	3.0000000000000003E-4	-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;L-Dopa	H2O;L-Dopaquinone	25.0	7.0	kcat*E*S/(Km+S)
72516	O2 + D-Dopa = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	kcat		10.844000000000001		0.40800000000000003	s^(-1)		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;D-Dopa	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72516	O2 + D-Dopa = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	D-Dopa	0.0	8.0E-4	-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;D-Dopa	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72516	O2 + D-Dopa = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	Enzyme			-	-		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;D-Dopa	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72516	O2 + D-Dopa = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	Km	D-Dopa	2.11E-4		2.2000000000000003E-5	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;D-Dopa	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72516	O2 + D-Dopa = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	O2	2.6000000000000002E-5		-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	O2;D-Dopa	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72517	L-Tyrosine + O2 = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	kcat		0.8710000000000001		0.08900000000000001	s^(-1)		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	L-Tyrosine;O2	L-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72517	L-Tyrosine + O2 = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	L-Tyrosine	0.0	1.0E-4	-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	L-Tyrosine;O2	L-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72517	L-Tyrosine + O2 = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	Enzyme			-	-		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	L-Tyrosine;O2	L-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72517	L-Tyrosine + O2 = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	O2	2.6000000000000002E-5		-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	L-Tyrosine;O2	L-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72517	L-Tyrosine + O2 = H2O + L-Dopaquinone	Agaricus bisporus	1.14.18.1	Km	L-Tyrosine	3.1E-5		5.0E-6	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	L-Tyrosine;O2	L-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72518	D-Tyrosine + O2 = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	kcat		0.8710000000000001		0.08900000000000001	s^(-1)		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	D-Tyrosine;O2	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72518	D-Tyrosine + O2 = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	Enzyme			-	-		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	D-Tyrosine;O2	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72518	D-Tyrosine + O2 = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	Km	D-Tyrosine	2.5E-4		2.1E-5	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	D-Tyrosine;O2	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72518	D-Tyrosine + O2 = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	O2	2.6000000000000002E-5		-	M		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	D-Tyrosine;O2	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72518	D-Tyrosine + O2 = H2O + D-Dopaquinone	Agaricus bisporus	1.14.18.1	concentration	D-Tyrosine			-	-		wildtype	monophenol monooxygenase	Fernandez-Julia PJ, Tudela-Serrano J, Garcia-Molina F, Garcia-Canovas F, Garcia-Jimenez A, Munoz-Munoz JL: Study of tyrosine and dopa enantiomers as tyrosinase substrates initiating l- and d-melanogenesis pathways., Biotechnol Appl Biochem 2020 (-) , -	32776353	D-Tyrosine;O2	D-Dopaquinone;H2O	25.0	7.0	kcat*E*S/(Km+S)
72815	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	ATP	0.0	1.0E-7	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72815	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72815	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	ATP	230.0		44.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72815	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	ATP	2.9999999999999996E-9		3.0E-10	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72815	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		7.5		0.19	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72816	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Remdesivir triphosphate	8.899999999999999E-10		1.0E-10	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72816	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Remdesivir triphosphate	0.0	1.3539999999999999E-8	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72816	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	Remdesivir triphosphate	840.0		143.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72816	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72816	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		7.4		0.22999999999999998	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72817	ATP + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72817	ATP + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Vmax/Km	ATP	250.0		63.0	-	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72817	ATP + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Vmax		7.3		0.17	-	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72817	ATP + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Km	ATP	2.9999999999999996E-9		3.0E-10	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72817	ATP + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	concentration	ATP	0.0	1.0E-7	-	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72818	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	concentration	Remdesivir triphosphate	0.0	1.3539999999999999E-8	-	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72818	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Vmax		7.0		0.15	-	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72818	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72818	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Vmax/Km	Remdesivir triphosphate	680.0		54.0	-	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72818	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS coronavirus	2.7.7.48	Km	Remdesivir triphosphate	1.0E-9		8.0E-11	M	P0C6X7	wildtype complex (nsp8/nsp12) (aa 3920-4117/4370-5301), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72819	ATP + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Km	ATP	7.2E-8		2.1E-8	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72819	ATP + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72819	ATP + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Vmax/Km	ATP	11.0		0.65	-	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72819	ATP + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Vmax		8.0		0.48	-	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72819	ATP + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	concentration	ATP	0.0	1.0E-7	-	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72820	Remdesivir triphosphate + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Km	Remdesivir triphosphate	2.5E-7		7.599999999999999E-8	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72820	Remdesivir triphosphate + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	concentration	Remdesivir triphosphate	0.0	1.3539999999999999E-8	-	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72820	Remdesivir triphosphate + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Vmax		7.0		0.47	-	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72820	Remdesivir triphosphate + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	Vmax/Km	Remdesivir triphosphate	2.8000000000000003		0.48	-	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72820	Remdesivir triphosphate + RNA = Diphosphate + RNA	Ebola virus	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	A0A068J9B1;X5GXU1	wildtype complex (L/VP35), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Remdesivir triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72821	ATP + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Km	ATP	1.1E-8		2.0E-9	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72821	ATP + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Vmax/Km	ATP	56.0		9.6	-	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72821	ATP + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	concentration	ATP	0.0	1.0E-7	-	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72821	ATP + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	concentration	Enzyme	2.0E-9		-	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72821	ATP + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Vmax		5.699999999999999		0.32	-	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72822	Remdesivir triphosphate + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	concentration	Enzyme	2.0E-9		-	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Remdesivir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72822	Remdesivir triphosphate + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Km	Remdesivir triphosphate	1.3E-7		1.8E-8	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Remdesivir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72822	Remdesivir triphosphate + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Vmax/Km	Remdesivir triphosphate	2.9		0.59	-	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Remdesivir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72822	Remdesivir triphosphate + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	Vmax		3.5		0.16	-	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Remdesivir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72822	Remdesivir triphosphate + RNA = Diphosphate + RNA	Lassa virus	2.7.7.48	concentration	Remdesivir triphosphate	0.0	1.0E-6	-	M	A0A097F4L1	wildtype RdRp L, N-terminal Strep-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Remdesivir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72823	2'-C-Methyl-adenosine triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	2'-C-Methyl-adenosine triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72823	2'-C-Methyl-adenosine triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	2'-C-Methyl-adenosine triphosphate	1.3		0.07	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	2'-C-Methyl-adenosine triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72823	2'-C-Methyl-adenosine triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	2'-C-Methyl-adenosine triphosphate	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	2'-C-Methyl-adenosine triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72823	2'-C-Methyl-adenosine triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	2'-C-Methyl-adenosine triphosphate	6.4E-7		3.7E-8	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	2'-C-Methyl-adenosine triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72823	2'-C-Methyl-adenosine triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		8.4		0.13	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	2'-C-Methyl-adenosine triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72824	dATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	dATP	2.7E-6		2.41E-7	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	dATP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72824	dATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	dATP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72824	dATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	dATP	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	dATP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72824	dATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	dATP	0.2		0.4	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	dATP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72824	dATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		6.3		0.21000000000000002	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	dATP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72825	ara-ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	ara-ATP	0.2		0.1	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ara-ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72825	ara-ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	ara-ATP	3.2999999999999997E-6		4.0599999999999996E-7	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ara-ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72825	ara-ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ara-ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72825	ara-ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	ara-ATP	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ara-ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72825	ara-ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		5.6000000000000005		0.31	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ara-ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72826	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	ATP	4.0E-9		6.0E-10	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72826	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	ATP	140.0		13.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72826	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72826	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		6.3		0.19	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72826	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	ATP	0.0	1.0E-7	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;ATP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72827	Favipiravir riboside triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Favipiravir riboside triphosphate	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Favipiravir riboside triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72827	Favipiravir riboside triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	Favipiravir riboside triphosphate	0.3		0.2	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Favipiravir riboside triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72827	Favipiravir riboside triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Favipiravir riboside triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72827	Favipiravir riboside triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		5.2		0.31	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Favipiravir riboside triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72827	Favipiravir riboside triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Favipiravir riboside triphosphate	2.1E-6		3.8999999999999997E-7	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;Favipiravir riboside triphosphate	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72828	RNA + CTP = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	CTP	1.0E-10		8.8E-12	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;CTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72828	RNA + CTP = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	CTP	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;CTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72828	RNA + CTP = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;CTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72828	RNA + CTP = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		7.199999999999999		0.22999999999999998	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;CTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72828	RNA + CTP = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	CTP	10220.0		1770.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;CTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72829	2'-Fluoro-dCTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	2'-Fluoro-dCTP	2.0E-9		3.0E-10	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;2'-Fluoro-dCTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72829	2'-Fluoro-dCTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	2'-Fluoro-dCTP	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;2'-Fluoro-dCTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72829	2'-Fluoro-dCTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;2'-Fluoro-dCTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72829	2'-Fluoro-dCTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		6.0		0.36	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;2'-Fluoro-dCTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72829	2'-Fluoro-dCTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	2'-Fluoro-dCTP	370.0		85.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	RNA;2'-Fluoro-dCTP	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72830	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	UTP	2.0E-9		3.0E-10	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	UTP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72830	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		7.5		0.21000000000000002	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	UTP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72830	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	UTP	390.0		93.0	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	UTP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72830	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	UTP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72830	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	UTP;RNA	RNA;Diphosphate	30.0	8.0	Vmax*S/(Km+S)
72831	Sofosbuvir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Sofosbuvir triphosphate	2.1E-6		2.2999999999999997E-7	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Sofosbuvir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72831	Sofosbuvir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax		7.7		0.3	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Sofosbuvir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72831	Sofosbuvir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Vmax/Km	Sofosbuvir triphosphate	0.4		0.1	-	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Sofosbuvir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72831	Sofosbuvir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Sofosbuvir triphosphate	0.0	9.999999999999999E-6	-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Sofosbuvir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72831	Sofosbuvir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.0E-8		-	M	P0DTD1	wildtype complex (nsp8/nsp12) (aa 3943-4140/4393-5324), N-terminal His-tag	RNA-directed RNA polymerase	Gordon CJ, Tchesnokov EP, Woolner E, Perry JK, Feng JY, Porter DP, Götte M: Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency, J Biol Chem 2020 (295) , 6785-6797	32284326	Sofosbuvir triphosphate;RNA	Diphosphate;RNA	30.0	8.0	Vmax*S/(Km+S)
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	2.5E-7	1.4999999999999999E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	2.0E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	UTP	1.3E-5		9.0E-7	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		30.8		1.7000000000000002	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72833	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	UTP	2300000.0		200000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	2.5E-7	1.4999999999999999E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	UTP	3.9999999999999996E-5		8.0E-6	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	2.0E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	UTP	1700000.0		500000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72834	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		68.0		13.0	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.25E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	ATP	3.2E-5		4.9999999999999996E-6	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	ATP	740000.0		160000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	ATP	5.0E-7	3.9999999999999996E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72835	ATP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		24.0		3.0	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	ATP;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.5E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Remdesivir triphosphate	3.5E-7	3.15E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Remdesivir triphosphate	5.3E-6		2.0E-7	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	Remdesivir triphosphate	1290000.0		60000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72836	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		6.800000000000001		0.2	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	Remdesivir triphosphate;RNA	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	Remdesivir triphosphate	190000.0		10000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Remdesivir triphosphate	3.5E-7	3.15E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Remdesivir triphosphate	1.9E-6		1.0E-7	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.5E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72837	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		0.36200000000000004		0.004	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	Remdesivir triphosphate	2.1E-6		2.0E-7	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Remdesivir triphosphate	3.5E-7	3.15E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		0.376		0.007000000000000001	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	1.5E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72838	Remdesivir triphosphate + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat/Km	Remdesivir triphosphate	180000.0		10000.0	M^(-1)*s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;Remdesivir triphosphate	RNA;Diphosphate	37.0	7.0	-
72839	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	kcat		22.0		2.3000000000000003	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	(E*kcat)*A/(Km+A)
72839	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Km	UTP	7.3999999999999995E-6		1.1E-6	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	(E*kcat)*A/(Km+A)
72839	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	2.0E-7		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	(E*kcat)*A/(Km+A)
72839	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	(E*kcat)*A/(Km+A)
72839	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	2.5E-7	1.4999999999999999E-5	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	(E*kcat)*A/(Km+A)
72840	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	2.0000000000000004E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	-
72840	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	Kd	UTP	1.8999999999999998E-7		2.0E-8	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	-
72840	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	Enzyme	2.0E-8	1.0E-6	-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	-
72840	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	1.4999999999999999E-5		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	Diphosphate;RNA	37.0	7.0	-
72841	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	rate const.		0.0013		1.0E-4	s^(-1)	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72841	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	RNA	1.0000000000000002E-8		-	M	P0DTD1	wildtype	RNA-directed RNA polymerase	Dangerfield TL, Huang NZ, Johnson KA: Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase, iScience 2020 (23) , 101849	33283177	RNA;UTP	RNA;Diphosphate	37.0	7.0	-
72841	UTP + RNA = Diphosphate + RNA	SARS-CoV-2	2.7.7.48	concentration	UTP	1.499999999999